1. Stewart A, Fisher RA. G Protein-coupled Receptors and RGS Proteins. Progress in Molecular Biology and Translational Science 133, 1-11(2015).
2. Latek D, Modzelewska A, Trzaskowski B, Palczewski K, Fillipek S. G protein-coupled receptors - recent advances. Acta Biochimica Polonica 59, 515-529(2012).
3. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology 63, 1256-1272(2003).
4. Hauser AS, Chavali S, Masuho I, Jahn LJ, Martemyanov KA, Gloriam DE, Babu MM. Pharmacogenomics of GPCR Drug Targets. Cell 172, 41-54(2018).
5. Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nature Reviews Drug Discovery 16, 829-842(2017).
6. Laschet C, Dupuis N, Hanson J. The G protein-coupled receptors deorphanization landscape. Biochemical Pharmacology 153, 62-74(2018).
7. Ali DC, Naveed M, Gordon A, Majeed F, Saeed M, Ogbuke MI, Atif M, Zubair HM, Changxing L. β-Adrenergic receptor, an essential target in cardiovascular diseases. Heart Failure Reviews, 1-12(2019).
8. Pfleger J, Gresham K, Koch WJ. G protein-coupled receptor kinases as therapeutic targets in the heart. Nature Reviews Cardiology 16, 612-622(2019).
9. Grisanti LA, Schumacher SM, Tilley DG, Koch WJ. Designer Approaches for G Protein–Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic to Translational Science 3, 550-562(2018).
10. Wang J, Gareri C, Rockman HA. G-Protein-Coupled Receptors in Heart Disease. Cirsulation Research 123, 716-735(2018).
11. Dhanasekaran N, Dermott JM. Signaling by the G12 class of G proteins. Cellular Signalling 8, 235-245(1996).
12. Strathmann MP, Simon MI. G alpha 12 and G alpha 13 subunits define a fourth class of G protein alpha subunits. Proceeding of the National Academy of Sciences of USA 88, 5582-5586(1991).
13. He Z, Yang Y, Wen Z, Chen C, Xu X, Zhu Y, Wang Y, Wang DW. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13. Journal of Lipid Research 58, 1338-1353(2017).
14. Ruppel KM, Willison D, Kataoka H, Wang A, Zheng YW, Cornelissen I, Yin L, Xu SM, Coughlin SR. Essential role for Galpha13 in endothelial cells during embryonic development. Proceeding of the National Academy of Sciences of USA 102, 8281-8286(2005).
15. Offermanns S, Mancino V, Revel JP, Simon MI. Vascular System Defects and Impaired Cell Chemokinesis as a Result of Gα13 Deficiency. Science24, 533-536(1997).
16. Takefuji M, Wirth A, Lukasova M, Takefuji S, Boettger T, Braun T, Althoff T, Offermanns S, Wettschureck N. G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure. Circulation 126, 1972-82(2012).
17. Azimzadeh P, Oison JA Jr, Balenga N. Reporter gene assays for investigating GPCR signaling. Methods Cell Biology 142, 89-99(2017).
18. Fan F, Wood KV. Bioluminescent Assays for High-Throughput Screening. Assay and Drug Development Technologies 5, 127-136 (2007).
19. Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, Austin CP, Auld DS. High-throughput screening assays for the identification of chemical probes. Nature Chemical Biology 3, 466-479(2007).
20. Liu Y, Hermes J, Li J, Tudor M. Endogenous Locus Reporter Assays. Methods in Molecular Biology 1755, 163-177(2018).
21. Liu B, Wu D. Analysis of the Coupling of G12/13 to G Protein-Coupled Receptors Using a Luciferase Reporter Assay. Methods in Molecular Biology 237, 145-149(2004).
22. Inoue A, Ishiguro J, Kitamura H, Arima N, Okutani M, Shuto A, Higashiyama S, Ohwada T, Arai H, Makide K, Aoki J. TGFα shedding assay: an accurate and versatile method for detecting GPCR activation. Nature Methods 9, 1021-1029(2012).
23. Inoue A, Raimondi F, Kadji FMN, Singh G, Kishi T, Uwamizu A, Ono Y, Shinjo Y, Ishida S, Arang N, Kawakami K, Gutkind JS, Aoki J, Russell RB. Illuminating G-Protein-Coupling Selectivity of GPCRs. Cell 177, 1933-1947(2019).
24. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Experimental Hematology 31, 1007-1014(2003).
25. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nature Protocols 8, 2281-2308(2013).
26. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
27. Mashiko D, Fujihara Y, Satouh Y, Miyata H, Isotani A, Ikawa M. Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA. Scientific Reports 3, 3355(2013).
28. Romanienko PJ, Giacalone J, Ingenito J, Wang Y, Isaka M, Johnson T, You Y, Mark WH. A Vector with a Single Promoter for In Vitro Transcription and Mammalian Cell Expression of CRISPR gRNAs. PLoS ONE 11, 12(2016).
29. Zhu P, Wu F, Mosenson J, Zhang H, He TC, Wu WS. CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy. Molecular Therapy Nucleic Acids 7, 31-41(2017).
30. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
31. Song AJ, Palmiter RD. Detecting and Avoiding Problems When Using the Cre-lox System. Trends Genet 34, 333-340(2018).
32. Geisinger JM, Turan S, Hernandez S, Spector LP, Calos MP. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining. Nucleic Acids Research 44, 76(2016).
33. Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, Kurita M, Hishida T, Li M, Aizawa E, Guo S, Chen S, Goebl A, Sologalla RD, Qu J, Jiang T, Fu X, Jafari M, Esteban CR, Berggren WT, Lajara J, Nunez-Delicado E, Guillen P, Campistol JM, Matsuzaki F, Liu GH, Magistretti P, Zhang K, Callaway EM, Zhang K, Belmonte JC. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature 540, 144-149(2016).
34. Suziki K, Izpisua Belmonte JC. In vivo genome editing via the HITI method as a tool for gene therapy. Journal of Human Genetics 63, 157-164(2018).
35. Stevens RC, Cherezov V, Katritch V, Abagyan R, Kuhn P, Rosen H, Wuthrich K. The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nature Reviews Drug Discovery 12, 25-34(2013).
36. Civelli O, Nothacker HP, Saito Y, Wang Z, Lin SH, Reinscheid RK. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends in Neurosciences 24, 230-237(2001).
37. Howard AD, McAllister G, Feighner SD, Liu Q, Nargund RP, Van der Ploeg LH, Patchett AA. Orphan G-protein-coupled receptors and natural ligand discovery. Trends in Pharmacological Sciences 22, 132-140(2001).
38. Van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends in Genetics 30, 418-426(2014).
39. Krupp M, Marquardt JU, Sahin U, Galle PR, Castle J, Teufel A. RNA-Seq Atlas—a reference database for gene expression profiling in normal tissue by next-generation sequencing. Bioinformatics 28, 1184-1185(2012).
40. Jeanneteau F, Barrere C, Vos M, De Vries CJM, Rouillard C, Levesque D, Dromard Y, Moisan MP, Duric V, Franklin TC, Duman RS, Lewis DA, Ginsberg SD, Arango-Lievano M. The Stress-Induced Transcription Factor NR4A1 Adjusts Mitochondrial Function and Synapse Number in Prefrontal Cortex. The Journal of neuroscience 38, 1335-1350(2018).
41. Ramazani Y, Knops N, Elmonem MA, Nguyen TQ, Arcolino FO, van den Heuvel L, Levtchenko E, Kuypers D, Goldschmeding R, Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biology 68-69, 44-66(2018).
42. Kull B, Arslan G, Nilsson C, Owman C, Lorenzen A, Schwabe U, Fredholm BB. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochemical Pharmacology 57, 65-75(1999).
43. Brasel CM, Sawyer GW, Stevens CW. A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function. European Journal of Pharmacology 599, 36-43(2008).
44. Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE Jr, Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RE. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor. European Journal of Pharmacology 449, 229-237(2002).